Tag: heart diseases

HOW DO WE IMPROVE MODELS THAT ARE NAÏVE TO REAL-WORLD ADHERENCE?

Seattle, WA, USA – Clinical trial patients often exhibit high medication adherence. But what happens in the real world? Medication adherence in routine practice is often lower and the effectiveness may differ. Models used to evaluate the cost- and comparative

Posted in Methodological Articles, Value in Health Tagged with: , , ,

Quality Of Life In Heart Patients: The Way You Measure Drives The Results

Gent, Belgium – Pain, anxiety, and functional or social limitations can cause an impaired Health-Related Quality of Life (HRQoL) in heart patients. Several measures exist to assess HRQoL, with some of them, such as the EQ-5D and the SF-6D (derived from

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , ,

Innovative Methods Uncover Differential Responders To Treatment

Manchester, UK – Variability in response to treatment (also called heterogeneity of treatment effects) is a common finding in clinical trials. Some variability is hypothesised and expected, such as differences between treatment and placebo groups, across doses, or between comparator drugs.

Posted in Methodological Articles, Value in Health Tagged with: , , , ,